TITLE

Brivanib alaninate

PUB. DATE
July 2015
SOURCE
Reactions Weekly;Jul2015, Vol. 1559 Issue 1, p39
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
An abstract of the article "Complete remission of hepatocellular carcinoma after transarterial Chemoembolization combined with brivanib," by J. Jia and colleagues is presented.
ACCESSION #
108302357

 

Related Articles

  • Sorafenib.  // Reactions Weekly;11/19/2011, Issue 1378, p31 

    The article describes a case of interstitial granulomatous drug reaction (IGDR) experienced by a 76-year-old man while he was receiving sorafenib for hepatocellular carcinoma with portalthrombosis.

  • Sorafenib/sunitinib.  // Reactions Weekly;12/1/2012, Issue 1430, p30 

    The article describes the case of a 48-year-old man with advanced hepatocellular after receiving sorafenib and sunitinib.

  • Sorafenib.  // Reactions Weekly;Mar2014, Vol. 1493 Issue 1, p41 

    The article presents a case study of a 59-year-old man who developed annular pustular psoriasis after treatment with sorafenib for hepatocellular carcinomas.

  • Sorafenib.  // Reactions Weekly;10/6/2012, Issue 1422, p44 

    The article describes seven cases of various toxicities in elderly patients, like anorexia and diarrhea, during treatment with sorafenib for hepatocellular carcinoma.

  • Sorafenib.  // Reactions Weekly;8/1/2013, Issue 1463, p34 

    The article presents a case study of a 50-year-old man with diarrhoea, which developed while being treated for hepatocellular carcinoma with sorafenib.

  • Sorafenib.  // Reactions Weekly;8/1/2013, Issue 1463, p34 

    The article presents a case study of an 80-year-old female patient with a small-intestinal haemorrhage, which developed while being treated with sorafenib for liver cancer.

  • Sorafenib.  // Reactions Weekly;7/6/2013, Issue 1460, p38 

    The article presents a case study of a 70-year-old man who developed rhabdomyolysis while being treated with sorafenib for advanced hepatocellular carcinoma.

  • Bromopyruvate.  // Reactions Weekly;6/9/2012, Issue 1405, p11 

    The article describes the case of a 16-year-old boy with fibrolamella hepatocellular carcinoma who experienced tumour lysis syndrome during treatment with bromopyruvate.

  • Survival higher among sorafenib recipients with certain ADRs.  // Reactions Weekly;12/18/2010, Issue 1332, p4 

    The article discusses a research study on the correlation between hand-foot-reaction and diarrhea and overall survival rate of patients with advanced hepatocellular carcinoma receiving sorafenib for advanced liver cancer, presented at the 61st Annual Meeting of the American Association for the...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics